Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Nature Communications|October 26, 2019
Genome-wide microhomologies enable precise template-free editing of biologically relevant deletion mutationsJanin Grajcarek, Jean Monlong, Yoko Nishinaka-Arai, et al.
Iscience|January 19, 2026
Embryonic lineage-specific iPSC-derived mesenchymal stem/stromal cells exhibit different morphologies and intrinsic functionsLinh Nguyen, Souta Motoike, Denise Zujur, et al.
Human Molecular Genetics|December 29, 2022
A mutation in DOK7 in congenital myasthenic syndrome forms aggresome in cultured cells, and reduces DOK7 expression and MuSK phosphorylation in patient-derived iPS cellsShaochuan Zhang, Bisei Ohkawara, Mikako Ito, et al.
NPJ Regenerative Medicine|September 15, 2022
Induction of functional xeno-free MSCs from human iPSCs via a neural crest cell lineageDaisuke Kamiya, Nana Takenaka-Ninagawa, Souta Motoike, et al.
Current Biology : CB|July 8, 2010
Metalloprotease-dependent onset of blood circulation in zebrafishAtsuo Iida, Kazuya Sakaguchi, Kiyoaki Sato, et al.
SLAS Technology|April 30, 2023
Screening Station, a novel laboratory automation system for physiologically relevant cell-based assaysIchiji Namatame, Kana Ishii, Takashi Shin, et al.
Stem Cells and Development|June 12, 2013
In vitro characterization and engraftment of adipocytes derived from human induced pluripotent stem cells and embryonic stem cellsMichio Noguchi, Kiminori Hosoda, Maiko Nakane, et al.
Scientific Reports|February 18, 2017
Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instabilityJunko Ueki, Masayuki Nakamori, Masahiro Nakamura, et al.
Stem Cell Reports|December 2, 2014
Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9Hongmei Lisa Li, Naoko Fujimoto, Noriko Sasakawa, et al.
Journal of Medicinal Chemistry|September 25, 2019
Identification of 2,6-Disubstituted 3<i>H</i>-Imidazo[4,5-<i>b</i>]pyridines as Therapeutic Agents for Dysferlinopathies through Phenotypic Screening on Patient-Derived Induced Pluripotent Stem CellsHiroyuki Takada, Akira Kaieda, Michiko Tawada, et al.
Pageof 11